title: Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.
abstract: The GA733 gene family is composed of GA733-1 (TROP2) and GA733-2 (Ep-CAM), whose expression has been examined in various carcinomas and reported to be significantly associated with prognosis. The aim of this study was to investigate the expression of GA733 gene family members and to compare their prognostic significance in pulmonary adenocarcinoma. One hundred thirty paraffin-embedded specimens of small-sized pulmonary adenocarcinoma, less than 2 cm in diameter, were categorized using the classification of small-sized pulmonary adenocarcinoma devised by Noguchi et al. (Cancer 75:2844-2852, 1995) and examined immunohistochemically using a murine monoclonal antibody against Ep-CAM and a goat polyclonal antibody against TROP2. The patient survival rate was calculated using the Kaplan-Meier method. Ep-CAM and TROP2 were similarly expressed in many small-sized pulmonary adenocarcinomas. The expression of Ep-CAM was significantly related to a favorable outcome (p = 0.0185), whereas TROP2 tended to be expressed in cases with an unfavorable outcome (p = 0.0564), and was significantly associated with an unfavorable outcome in nonlepidic-type adenocarcinomas (p = 0.0125). Multivariate analysis showed that TROP2 overexpression and lymph node metastasis were independent prognostic markers. Although the two GA733 proteins share structural similarity, they appear to have opposite biological significances in small-sized adenocarcinomas. As the expression of TROP2 was detected in more poorly differentiated tumors, the protein may have oncogenic activity.
authors.affiliation: Department of Pathology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki, 305-8575, Japan.
authors.forename: Hiromi
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Yuko
authors.initials: Y
authors.lastname: Minami
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Anami
authors.forename: Yuzuru
authors.initials: Y
authors.lastname: Kondou
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Iijima
authors.forename: Junko
authors.initials: J
authors.lastname: Kano
authors.forename: Yukio
authors.initials: Y
authors.lastname: Morishita
authors.forename: Koji
authors.initials: K
authors.lastname: Tsuta
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Hayashi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Noguchi
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism* / Q000401:mortality; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000096:biosynthesis* / Q000235:genetics; D014408:Biomarkers, Tumor / Q000032:analysis*; D015815:Cell Adhesion Molecules / Q000096:biosynthesis* / Q000235:genetics; D000071858:Epithelial Cell Adhesion Molecule; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015815:Cell Adhesion Molecules; C499379:EPCAM protein, human; D000071858:Epithelial Cell Adhesion Molecule
references.citation: BMC Cancer. 2006 Jun 23;6:165
references.pmid: 16796747
references.citation: Clin Cancer Res. 2004 Aug 15;10(16):5464-71
references.pmid: 15328185
references.citation: J Clin Oncol. 1999 Jan;17(1):19-24
references.pmid: 10458213
references.citation: Cell Adhes Commun. 1994 Oct;2(5):417-28
references.pmid: 7842256
references.citation: Mod Pathol. 2008 Feb;21(2):186-91
references.pmid: 18084248
references.citation: Int J Cancer. 2002 Apr 20;98(6):883-8
references.pmid: 11948467
references.citation: Proc Natl Acad Sci U S A. 1989 Jan;86(1):27-31
references.pmid: 2911574
references.citation: Clin Cancer Res. 2004 May 1;10(9):3131-6
references.pmid: 15131054
references.citation: Mol Cell Biol. 1993 Mar;13(3):1507-15
references.pmid: 8382772
references.citation: Cancer. 1995 Jun 15;75(12):2844-52
references.pmid: 7773933
references.citation: Cancer Sci. 2005 Oct;96(10):668-75
references.pmid: 16232198
references.citation: Nat Genet. 1999 Apr;21(4):420-3
references.pmid: 10192395
references.citation: Int J Cancer. 1998 May 29;76(5):671-6
references.pmid: 9610724
references.citation: Proc Natl Acad Sci U S A. 1990 May;87(9):3542-6
references.pmid: 2333300
references.citation: Mod Pathol. 2007 Feb;20(2):221-32
references.pmid: 17361206
references.citation: Breast Cancer Res Treat. 2004 Aug;86(3):207-13
references.pmid: 15567937
references.citation: J Mol Med (Berl). 1999 Oct;77(10):699-712
references.pmid: 10606205
references.citation: Gynecol Oncol. 2006 Nov;103(2):483-8
references.pmid: 16678891
references.citation: Hum Pathol. 2000 Apr;31(4):482-7
references.pmid: 10821496
references.citation: Crit Rev Oncol Hematol. 2001 Oct;40(1):17-24
references.pmid: 11578913
references.citation: Br J Cancer. 2005 May 9;92(9):1767-72
references.pmid: 15870832
references.citation: Clin Cancer Res. 2006 May 15;12(10):3057-63
references.pmid: 16707602
references.citation: Genes Chromosomes Cancer. 2001 Jul;31(3):209-20
references.pmid: 11391791
references.citation: Lancet. 2000 Dec 9;356(9246):1981-2
references.pmid: 11130529
references.citation: J Natl Cancer Inst. 1998 May 6;90(9):691-7
references.pmid: 9586666
references.citation: Clin Cancer Res. 2008 Sep 15;14(18):5849-55
references.pmid: 18794096
references.citation: Br J Cancer. 2008 Oct 21;99(8):1290-5
references.pmid: 18813308